Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery

Gene Ther. 2004 Mar;11(5):457-64. doi: 10.1038/sj.gt.3302183.

Abstract

In this study, we investigated to what extent the stability and transduction capacity of polyplexed DNA can be improved by optimizing the condensing peptide sequence. We have synthesized a small library of cationic peptides, at which the lysine/arginine ratio and the cation charge were varied. All peptides were able to compact DNA, at which polyplexes of short lysine-rich sequences were considerably larger than those of elongated or arginine-rich peptides (GM102 and GM202). In addition, the arginine-rich peptides GM102 and GM202 rendered the polyplexes resistant to plasma incubation or DNase I-mediated digestion. While all peptides were found to improve the transfection efficiency in HepG2 cells, only the GM102- and GM202-derived polyplexes could be specifically targeted to HepG2 cells by incorporation of a ligand-derivatized YKAK(8)WK peptide. We propose that GM102 and GM202 combine the advantage of small condensing peptides to give small-sized polyplexes with the superior stability of condensing polymers, which makes GM102 and GM202 excellent candidates for future in vivo gene therapy studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Arginine / chemistry*
  • Chemical Phenomena
  • Chemistry, Physical
  • Deoxyribonuclease I / chemistry
  • Drug Stability
  • Gene Targeting / methods
  • Gene Transfer Techniques*
  • Genetic Vectors / chemistry*
  • Genetic Vectors / pharmacokinetics
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Molecular Sequence Data
  • Oligopeptides / chemistry*
  • Oligopeptides / genetics
  • Oligopeptides / pharmacokinetics
  • Peptide Fragments / chemistry
  • Tissue Distribution
  • Transduction, Genetic
  • Transfection

Substances

  • Oligopeptides
  • Peptide Fragments
  • Arginine
  • Deoxyribonuclease I